Tirzepatide is a once-weekly injectable dual glucagon-like peptide 1 (GLP-1) receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
Association between sleep disorders and constipation risk: a systematic review and meta-analysis
We provide regulated prescriptions, clear guidance, and ongoing support to help you manage your health safely
Equinox and LifeTime Fitness have begun offering tailored GLP-1 weight-loss programs to members
Individual timelines vary based on starting dose, calorie deficit, nutrition quality, and genetics
Current serotonin medications are aimed at increasing central 5-HT neurotransmission in the brain, and there are no approved indications for manipulating peripheral 5-HT, though peripheral 5-HT synthesis is being considered as a potential target for developing pharmacological agents in some disorders (8, 9)